Brief: Kang Stem Biotech receives Europe patent
05/07/2018 08:01
July 5 (Reuters) - Kang Stem Biotech Co Ltd 217730.KQ :
* Says it received Europe patent on July 5, for equine
amniotic
fluid-derived multipotent stem cells and a method for producing
the same
Source text in Korean : https://goo.gl/de98zD
Further company coverage: 217730.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Kang Stem Biotech
See all newsBrief: Kangstem Biotech To Conduct Capital Increase Of 49 Billion Won
Brief: Kangstem Biotech To Conduct Capital Increase Of 35.7 Billion Won
Brief: Kang Stem Biotech to invest 8.76 bln won in facilities extension
Brief: Kang Stem Biotech receives patent
Brief: Kang Stem Biotech raises 35.95 bln won via rights issue